Your browser doesn't support javascript.
COVID-19 vaccine acceptance among high-risk populations in Uganda.
Bongomin, Felix; Olum, Ronald; Andia-Biraro, Irene; Nakwagala, Frederick Nelson; Hassan, Khalid Hudow; Nassozi, Dianah Rhoda; Kaddumukasa, Mark; Byakika-Kibwika, Pauline; Kiguli, Sarah; Kirenga, Bruce J.
  • Bongomin F; Department of Medical Microbiology and Immunology, Faculty of Medicine, Gulu University, P.O. Box 166, Gulu, Uganda.
  • Olum R; Department of Medicine, School of Medicine, Makerere University College of Health Sciences, Kampala, Uganda.
  • Andia-Biraro I; Department of Medicine, School of Medicine, Makerere University College of Health Sciences, Kampala, Uganda.
  • Nakwagala FN; Department of Medicine, Mulago National Referral Hospital, Kampala, Uganda.
  • Hassan KH; Department of Medicine, School of Medicine, Makerere University College of Health Sciences, Kampala, Uganda.
  • Nassozi DR; Department of Dentistry, School of Health Sciences, Makerere University College of Health Sciences, Kampala, Uganda.
  • Kaddumukasa M; Department of Medicine, School of Medicine, Makerere University College of Health Sciences, Kampala, Uganda.
  • Byakika-Kibwika P; Department of Medicine, School of Medicine, Makerere University College of Health Sciences, Kampala, Uganda.
  • Kiguli S; Department of Pediatrics & Child Health, School of Medicine, Makerere University College of Health Sciences, Kampala, Uganda.
  • Kirenga BJ; Department of Medicine, School of Medicine, Makerere University College of Health Sciences, Kampala, Uganda.
Ther Adv Infect Dis ; 8: 20499361211024376, 2021.
Article in English | MEDLINE | ID: covidwho-1269865
ABSTRACT

BACKGROUND:

Immunization is an important strategy for controlling the COVID-19 pandemic. COVID-19 vaccination was recently launched in Uganda, with prioritization to healthcare workers and high-risk individuals. In this study, we aimed to determine the acceptability of COVID-19 vaccine among persons at high risk of COVID-19 morbidity and mortality in Uganda.

METHODS:

Between 29 March and 14 April 2021, we conducted a cross-sectional survey consecutively recruiting persons at high risk of severe COVID-19 (diabetes mellitus, HIV and cardiovascular disease) attending Kiruddu National Referral Hospital outpatient clinics. A trained research nurse administered a semi-structured questionnaire assessing demographics, COVID-19 vaccine related attitudes and acceptability. Descriptive statistics, bivariate and multivariable analyses were performed using STATA 16.

RESULTS:

A total of 317 participants with a mean age 51.5 ± 14.1 years were recruited. Of this, 184 (60.5%) were female. Overall, 216 (70.1%) participants were willing to accept the COVID-19 vaccine. The odds of willingness to accept COVID-19 vaccination were four times greater if a participant was male compared with if a participant was female [adjusted odds ratio (AOR) 4.1, 95% confidence interval (CI) 1.8-9.4, p = 0.00]. Participants who agreed (AOR 0.04, 95% CI 0.01-0.38, p = 0.003) or strongly agreed (AOR 0.04, 95% CI 0.01-0.59, p = 0.005) that they have some immunity against COVID-19 were also significantly less likely to accept the vaccine. Participants who had a history of vaccination hesitancy for their children were also significantly less likely to accept the COVID-19 vaccine (AOR 0.1, 95% CI 0.01-0.58, p = 0.016).

CONCLUSION:

The willingness to receive a COVID-19 vaccine in this group of high-risk individuals was comparable to the global COVID-19 vaccine acceptance rate. Increased sensitization, myth busting and utilization of opinion leaders to encourage vaccine acceptability is recommended.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Observational study / Prognostic study / Qualitative research / Randomized controlled trials Topics: Vaccines Language: English Journal: Ther Adv Infect Dis Year: 2021 Document Type: Article Affiliation country: 20499361211024376

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Observational study / Prognostic study / Qualitative research / Randomized controlled trials Topics: Vaccines Language: English Journal: Ther Adv Infect Dis Year: 2021 Document Type: Article Affiliation country: 20499361211024376